AAAAAA

   
Results: 1-8 |
Results: 8
ASSIGNMENT OF THE HUMAN B-CELL-DERIVED (BCD1) PROTOONCOGENE TO 10P14-P15
Authors: ELROUBY S RAO PH NEWCOMB EW
Citation: S. Elrouby et al., ASSIGNMENT OF THE HUMAN B-CELL-DERIVED (BCD1) PROTOONCOGENE TO 10P14-P15, Genomics, 43(3), 1997, pp. 395-397
IDENTIFICATION OF BCD A NOVEL PROTOONCOGENE EXPRESSED IN B-CELLS
Authors: ELROUBY S NEWCOMB EW
Citation: S. Elrouby et Ew. Newcomb, IDENTIFICATION OF BCD A NOVEL PROTOONCOGENE EXPRESSED IN B-CELLS, Oncogene, 13(12), 1996, pp. 2623-2630
DRUG-INDUCED APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RELATIONSHIP BETWEEN P53 GENE MUTATION AND BCL-2 BAX PROTEINS IN DRUG-RESISTANCE/
Authors: THOMAS A ELROUBY S REED JC KRAJEWSKI S SILBER R POTMESIL M NEWCOMB EW
Citation: A. Thomas et al., DRUG-INDUCED APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RELATIONSHIP BETWEEN P53 GENE MUTATION AND BCL-2 BAX PROTEINS IN DRUG-RESISTANCE/, Oncogene, 12(5), 1996, pp. 1055-1062
A UNIQUE SPECTRUM OF P53 MUTATIONS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA DISTINCT FROM THAT OF OTHER LYMPHOID MALIGNANCIES
Authors: NEWCOMB EW ELROUBY S THOMAS A
Citation: Ew. Newcomb et al., A UNIQUE SPECTRUM OF P53 MUTATIONS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA DISTINCT FROM THAT OF OTHER LYMPHOID MALIGNANCIES, Molecular carcinogenesis, 14(4), 1995, pp. 227-232
IDENTIFICATION OF MELANOMA CELL-SURFACE ANTIGENS IMMUNOGENIC IN MICE
Authors: JOHNSTON D ELROUBY S BYSTRYN JC
Citation: D. Johnston et al., IDENTIFICATION OF MELANOMA CELL-SURFACE ANTIGENS IMMUNOGENIC IN MICE, Cancer biotherapy, 9(1), 1994, pp. 29-38
FEATURES OF A NOVEL HUMAN GENE WHOSE EXPRESSION IS RESTRICTED TO NORMAL CD19-CELLS AND IS DOWN-REGULATED IN MALIGNANT B-CELLS FROM B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) PATIENTS( B)
Authors: ELROUBY S NEWCOMB EW
Citation: S. Elrouby et Ew. Newcomb, FEATURES OF A NOVEL HUMAN GENE WHOSE EXPRESSION IS RESTRICTED TO NORMAL CD19-CELLS AND IS DOWN-REGULATED IN MALIGNANT B-CELLS FROM B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) PATIENTS( B), Blood, 84(10), 1994, pp. 10000454-10000454
P53 GENE MUTATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATED WITH DRUG-RESISTANCE AND IS INDEPENDENT OF MDR1 MDR3 GENE-EXPRESSION/
Authors: ELROUBY S THOMAS A COSTIN D ROSENBERG CR POTMESIL M SILBER R NEWCOMB EW
Citation: S. Elrouby et al., P53 GENE MUTATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATED WITH DRUG-RESISTANCE AND IS INDEPENDENT OF MDR1 MDR3 GENE-EXPRESSION/, Blood, 82(11), 1993, pp. 3452-3459
IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION
Authors: COSTIN D POTMESIL M NEWCOMB EW ELROUBY S THOMAS A DRYGAS J MORSE L SILBER R
Citation: D. Costin et al., IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION, Blood, 82(10), 1993, pp. 10000043-10000043
Risultati: 1-8 |